1. Home
  2. INTS vs XBP Comparison

INTS vs XBP Comparison

Compare INTS & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • XBP
  • Stock Information
  • Founded
  • INTS 2012
  • XBP N/A
  • Country
  • INTS United States
  • XBP United Kingdom
  • Employees
  • INTS N/A
  • XBP N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • XBP Business Services
  • Sector
  • INTS Health Care
  • XBP Consumer Discretionary
  • Exchange
  • INTS Nasdaq
  • XBP Nasdaq
  • Market Cap
  • INTS 33.4M
  • XBP 31.2M
  • IPO Year
  • INTS 2023
  • XBP N/A
  • Fundamental
  • Price
  • INTS $2.41
  • XBP $1.00
  • Analyst Decision
  • INTS Strong Buy
  • XBP
  • Analyst Count
  • INTS 3
  • XBP 0
  • Target Price
  • INTS $8.50
  • XBP N/A
  • AVG Volume (30 Days)
  • INTS 40.1K
  • XBP 29.2K
  • Earning Date
  • INTS 03-13-2025
  • XBP 11-12-2024
  • Dividend Yield
  • INTS N/A
  • XBP N/A
  • EPS Growth
  • INTS N/A
  • XBP N/A
  • EPS
  • INTS N/A
  • XBP N/A
  • Revenue
  • INTS N/A
  • XBP $157,146,000.00
  • Revenue This Year
  • INTS N/A
  • XBP N/A
  • Revenue Next Year
  • INTS N/A
  • XBP N/A
  • P/E Ratio
  • INTS N/A
  • XBP N/A
  • Revenue Growth
  • INTS N/A
  • XBP N/A
  • 52 Week Low
  • INTS $1.50
  • XBP $0.79
  • 52 Week High
  • INTS $5.94
  • XBP $4.33
  • Technical
  • Relative Strength Index (RSI)
  • INTS 54.20
  • XBP 42.52
  • Support Level
  • INTS $2.00
  • XBP $0.97
  • Resistance Level
  • INTS $2.37
  • XBP $1.10
  • Average True Range (ATR)
  • INTS 0.31
  • XBP 0.07
  • MACD
  • INTS -0.00
  • XBP -0.00
  • Stochastic Oscillator
  • INTS 48.24
  • XBP 15.15

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About XBP XBP Europe Holdings Inc.

XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.

Share on Social Networks: